Vertex Pharmaceuticals (VRTX) Depreciation & Amortization (CF) (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Depreciation & Amortization (CF) of $56.5 million for Q2 2026, up 9.3% from $51.7 million a year earlier and up 1.1% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Vertex Pharmaceuticals was $222.1 million, up 11.2% year-over-year; for FY2025, it was $209.8 million, up 1.3% from FY2024.
- Annual Depreciation & Amortization (CF) has increased for eight consecutive years, with a five-year compound annual growth rate of 13.9% (FY2020 to FY2025).
- In prior years, Vertex Pharmaceuticals' Depreciation & Amortization (CF) was $207.2 million in FY2024 (+14.3%), $181.3 million in FY2023 (+22.3%), $148.3 million in FY2022 (+18.1%) and $125.6 million in FY2021 (+14.7%).
- The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q4 2023.
- On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last four quarters, with growth averaging 4.7% over the last eight quarters.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2023, with growth of 53.6%; the weakest was Q4 2024, with a decline of 21.2%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $55.9 million (Q1 2026), $55.7 million (Q4 2025) and $54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 56.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.50 Mn |
| Mar 31, 2026 | 55.90 Mn |
| Dec 31, 2025 | 55.70 Mn |
| Sep 30, 2025 | 54.00 Mn |
| Jun 30, 2025 | 51.70 Mn |
| Mar 31, 2025 | 48.40 Mn |
| Dec 31, 2024 | 46.50 Mn |
| Sep 30, 2024 | 53.20 Mn |
| Jun 30, 2024 | 54.00 Mn |
| Mar 31, 2024 | 53.50 Mn |
| Dec 31, 2023 | 59.00 Mn |
| Sep 30, 2023 | 42.10 Mn |
| Jun 30, 2023 | 41.40 Mn |
| Mar 31, 2023 | 38.80 Mn |
| Dec 31, 2022 | 38.40 Mn |
| Sep 30, 2022 | 36.70 Mn |
| Jun 30, 2022 | 37.30 Mn |
| Mar 31, 2022 | 35.90 Mn |
| Dec 31, 2021 | 33.80 Mn |
| Sep 30, 2021 | 31.70 Mn |
API Access
Vertex Pharmaceuticals Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();